JAMA PATTERSON: Open Payments
NPI 1104343714 · HENDERSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,088 in 70 payments from 16 companies in 2025. Trend: 2023 $1,292 · 2024 $1,066 · 2025 $1,088
Food & beverage: $1,088
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $351 |
| PFIZER INC. | 11 | $162 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $119 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| Novo Nordisk Inc | 4 | $64 |
| Phathom Pharmaceuticals, Inc. | 4 | $56 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| Amgen Inc. | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Medtronic, Inc. | 1 | $29 |
Products named: UBRELVY, CAPLYTA, QULIPTA, REXULTI, ELIQUIS, Ozempic, VOQUEZNA, PREVNAR 20.
Industry payments across KY — which companies pay providers there.
